Similar articles

• Pituitary thyroid function and prolactin release following intravenous administration of TRH and pyroglutamyl-histidyl-prolyl-β alanine amide to healthy volunteers.

  Taaffe WP, Lambe RF, O'Kelly DA, Darragh A. Taaffe WP, et al. Ir J Med Sci. 1979 Dec;148(1):181. doi: 10.1007/BF02938076. Ir J Med Sci. 1979. PMID: 27517414
• Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio.

  Kagabu Y, Mishiba T, Okino T, Yanagisawa T. Kagabu Y, et al. Gen Comp Endocrinol. 1998 Sep;111(3):395-403. doi: 10.1006/gcen.1998.7124. Gen Comp Endocrinol. 1998. PMID: 9707485
• Thyroid function in patients with fibromyalgia syndrome.

  Neeck G, Riedel W. Neeck G, et al. J Rheumatol. 1992 Jul;19(7):1120-2. J Rheumatol. 1992. PMID: 1512769
• Pyroglutamyl-histidyl-prolineamide (TRH). A neurohormone which affects the release and synthesis of prolactin and thyrotropin.

  Dannies PS, Tashjian AH Jr. Dannies PS, et al. Isr J Med Sci. 1974 Oct;10(10):1294-304. Isr J Med Sci. 1974. PMID: 4215776 Review. No abstract available.
• Tripeptide amide L-pyroglutamyl-histidyl-L-prolineamide (L-PHP-thyrotropin-releasing hormone, TRH) promotes insulin-producing cell proliferation.

  Luo L, Luo JZ, Jackson I. Luo L, et al. Curr Aging Sci. 2013 Feb;6(1):8-13. doi: 10.2174/1874609811306010002. Curr Aging Sci. 2013. PMID: 23895518 Review.